MONOVISC®

​MONOVISC™ is a high molecular weight hyaluronan injection therapy designed to alleviate knee pain caused by osteoarthritis. This non-avian sourced hyaluronic acid injection has demonstrated clinically proven efficacy, providing relief with a single injection that can last up to six months.

For individuals seeking effective relief from knee osteoarthritis pain, exploring MONOVISC™ injection therapy may be beneficial. Consulting with an orthopaedic specialist can provide personalized information on treatment suitability and potential outcomes.

How does the MONOVISC injection work?

MONOVISC is a single-injection viscosupplement composed of high molecular weight hyaluronic acid (HA), specifically sodium hyaluronate, derived from non-avian sources. In the context of knee osteoarthritis (OA), HA serves as a crucial component of synovial fluid, acting as a lubricant and shock absorber within the joint. However, in OA patients, the natural HA in the knee joint diminishes, leading to increased friction, pain, and reduced mobility.​

When administered via the MONOVISC injection, the exogenous HA integrates into the synovial fluid, restoring its viscoelastic properties. This restoration enhances joint lubrication, reduces pain, and improves function. Moreover, HA has been observed to exert moderate anti-inflammatory effects, further alleviating OA symptoms. Notably, MONOVISC has demonstrated pain relief that can last up to six months with a single injection.

MONOVISC Orthopaedic Injectable Administration

The administration of MONOVISC is performed by an orthopaedic specialist through a single intra-articular injection directly into the affected knee joint. Before injection, any excess synovial fluid may be aspirated to ensure accurate delivery of the MONOVISC solution. The procedure is conducted under sterile conditions to minimize the risk of infection, adhering to standard aseptic techniques.

Moreover, MONOVISC represents a valuable treatment option for knee OA management. It offers patients relief from pain and improvement in joint function. Its administration should be performed by qualified healthcare professionals, following established guidelines to ensure safety and efficacy.

​Understanding the indications and contraindications for MONOVISC is crucial for both healthcare providers and patients to ensure effective management of knee osteoarthritis (OA) pain. This treatment aims to enhance joint lubrication and alleviate discomfort associated with OA. Familiarity with its approved indications and avoiding the precautions help identify appropriate candidates and optimize therapeutic outcomes.

MONOVISC Indications

The recommended dosage is a single 4 mL injection, which has been shown to significantly relieve pain in patients. Furthermore, MONOVISC™ is indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen).

MONOVISC Contraindications

The product is contraindicated in patients with known hypersensitivity to hyaluronic acid or any of its components. Additionally, individuals with infections or skin diseases at the injection site should not receive the injection. Pregnant or breastfeeding women, as well as those with allergies to avian proteins, should consult their healthcare provider before treatment.

​A thorough understanding of the MONOVISC product’s composition and packaging is vital for aesthetic providers to ensure patient safety during cosmetic procedures. Equipping patients with comprehensive education about the MONOVISC injection enables them to make informed decisions regarding their treatment options.

The Injectable’s Composition

​MONOVISC is a single-injection viscosupplement designed to alleviate knee pain associated with osteoarthritis. This MONOVISC injection consists of a sterile, non-pyrogenic solution of sodium hyaluronate (NaHA), a high molecular weight hyaluronic acid derived from bacterial fermentation.

• Using a proprietary agent, the NaHA is lightly cross-linked, enhancing its viscoelastic properties to lubricate and cushion the knee joint effectively.

Packaging of MONOVISC Product

​It comes in a 5 mL pre-filled syringe containing 4 mL of the MONOVISC gel, which provides a high concentration of sodium hyaluronate to effectively lubricate the knee joint. This MONOVISC product is manufactured using ultra-pure, high-molecular-weight hyaluronan derived from bacterial fermentation, ensuring both safety and efficacy.

The syringe is designed for single use only, and any unused portion should be discarded. Proper storage and handling of MONOVISC are essential to maintaining its integrity and effectiveness.

​The proper usage, administration, and dosing of MONOVISC are critical to achieving optimal outcomes in knee pain management. Healthcare professionals should adhere to the guidelines provided by the manufacturer to ensure patient safety and treatment efficacy.

• MONOVISC™ Cross-Linked Sodium Hyaluronate Injection is a single, intra-articular injection of cross-linked sodium hyaluronate designed to treat the symptoms of osteoarthritis.
• Strict aseptic injection technique should be used during the application of Monovisc™.
• MONOVISC injection is designed to replace or supplement synovial fluid.
• MONOVISC™ provides as much HA in a single injection as three injections of ORTHOVISC.
• High molecular weight HA provides excellent physical properties.
• Ergonomic syringe delivers safe, effective, easy injectability through 18-21 gauge needle.

Detailed instructions on administration techniques and dosage recommendations are available on the official MONOVISC website.

Post-Treatment Care

​After receiving a MONOVISC injection, it’s advisable to adhere to these guidelines to support the patient’s recovery and maximize the benefits of the MONOVISC treatments.

• For 48 hours, refrain from activities that place excessive strain on your knee, such as jogging, heavy lifting, or prolonged standing (over one hour).
• Expect common side effects, including transient pain, swelling, or stiffness at the injection site, which may resolve independently within a few days to a week.
• Applying a cold pack to your knee for 10 to 15 minutes every 4 hours can help alleviate discomfort.

As with any invasive joint procedure, it is recommended that patients regularly have appointments with their trusted medical providers to sustain optimal outcomes and avoid potential risks.

Where To Buy MONOVISC

For healthcare professionals and medical spas interested in incorporating this effective treatment into their offerings, acquiring MONOVISC through reputable suppliers like Med Supply Solutions ensures access to authentic products at competitive prices.​

Med Supply Solutions, a trusted provider of medical supplies, offers MONOVISC for purchase on their website. By placing orders directly through their platform, you can be confident in the quality and authenticity of the products received. This approach streamlines inventory management for medical spas and healthcare facilities, ensuring timely access to essential treatments for patients seeking relief from knee pain.​

Incorporating MONOVISC into your practice not only enhances the range of treatments available but also aligns with the growing demand for effective, minimally invasive solutions for osteoarthritis. By sourcing MONOVISC through Med Supply Solutions, you support your commitment to providing patients with high-quality care and access to advanced therapeutic options.